Methylene blue reduces postoperative delirium in mice through neuroinflammation suppression and blood-brain barrier repair

Yixu Deng, Jie Hua, Hongcen Pan, Jun Zhang · 2025

Read Methylene blue reduces postoperative delirium in mice through neuroinflammation suppression and blood-brain barrier repair by Yixu Deng, Jie Hua, Hongcen Pan, Jun Zhang (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12658177.txt.

Description

Postoperative delirium (POD) is a serious complication following anesthesia and surgery, with currently unclear pathogenesis and no effective treatments. In recent years, emerging evidence implicates that neuroinflammatory and blood-brain barrier (BBB) dysfunction play an important role in the pathogenesis of POD. Methylene blue (MB), an FDA-approved drug, has been reported to have anti-inflammatory and neuroprotective properties.

Catalog record

CREATORYixu Deng, Jie Hua, Hongcen Pan, Jun Zhang
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE47 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12658177

Browse the full library · About the Tower of Babel